Ras/mitogen-activated protein kinase mediates norepinephrine-induced phospholipase D activation in rabbit aortic smooth muscle cells by a phosphorylation-dependent mechanism

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 1, 2000, Pages 268-274

  Muthalif, Mubarack M ^a   Parmentier, Jean Hugues ^a   Benter, Ibrahim F ^b   Karzoun, Nour ^b   Ahmed, Aftab ^a   Khandekar, Zinat ^a   Adl, Mohamed Z ^a   Bourgoin, Sylvain ^c   Malik, Kafait U ^a  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b SOUTHERN COLLEGE OF OPTOMETRY   (United States)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; NORADRENALIN; PHOSPHOLIPASE D; RAS PROTEIN;

ANIMAL CELL; AORTA MEDIA; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REGULATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BETA-GALACTOSIDASE; BLOTTING, WESTERN; CALCIUM; ENZYME ACTIVATION; GENES, RAS; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; PHOSPHOLIPASE D; PHOSPHORYLATION; PRECIPITIN TESTS; RABBITS;

EID: 0034038211     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Al-Shami A, Gilbert C, Barabe C, Gaudry M and Naccache P (1998) Preservation of the pattern of tyrosine phosphorylation in human neutrophil lysates. J Immunol Methods 202:183-191.
2. Bae CD, Min DS, Fleming IN and Exton JH (1998) Determination of interaction sites on the small G protein RhoA for PLD. J Biol Chem 273:11596-11604.
3. 1-adrenergic receptors in Madin-Darby canine kidney cells is independent of PKCα and -ε activation. Mol Pharmacol 53:221-227.
4. Brown HA, Gutowski S, Moomaw CR, Slaughter C and Sternweis PC (1993) ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates PLD activity. Cell 75:1137-1144.
5. Carnero A, Cuadrado A, del Peso L and Lacal JC (1994) Activation of type D phospholipase by serum stimulation and ras-induced transformation in NIH3T3 cells. Oncogene 9:1387-1395.
6. del Peso L, Hernandez R, Esteve P and Lacal JC (1996) Activation of phospholipase D by ras proteins is independent of PKC. J Cell Biochem 61:599-608.
7. Exton JH (1994) Phosphatidylcholine breakdown and signal transduction. Biochim Biophys Acta 1212:26-42.
8. Exton JH (1997) PLD: Enzymology mechanism of regulation, and function. Physiol Rev 77:303-320.
9. 2+ and PKC in the activation of PLD by angiotensin in vascular smooth muscle cells. Arch Biockem Biophys 319:84-92.
10. Ghosh S, Strum JC, Sciorra VA, Daniel L and Bell RM (1996) Raf-1 kinase possesses distinct binding domains for phosphatidylserine and phosphatidic acid. Phosphatidic acid regulates the translocation of Raf-1 in 12-O-tetradecanoylphorbol-13-acetate-stimulated Madin-Darby canine kidney cells. J Biol Chem 271:8472-8480.
11. Gibbs JB and Oliff A (1997) The potential of farnesyltransferase inhibitors as cancer chem-therapeutics. Annu Rev Pharmacol Toxicol 37:143-166.
12. Gu H, Trajkovic S and LaBelle EF (1992) Norepinephrine-induced phosphatidylcholine hydrolysis by PLD and PLC in rat tail artery. Am J Physiol 262:C1376-C1383.
13. 1. J Biol Chem 272:3860-3868.
14. 1Adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells. Role in mitogenesis. J Biol Chem 271:8977-8982.
15. Jiang H, Lu Z, Luo J, Wolfman A and Foster DA (1995a) Ras mediates the activation of PLD by v-Src. J Biol Chem 270:6006-6009.
16. Jiang H, Luo JQ, Urano T, Frankel P, Lu Z, Foster DA and Feig LA (1995b) Involvement of Ra1 GTPase in v-Src-induced PLD activation. Nature (Lond) 378: 409-412.
17. Jones LG, Ella KM, Bradshaw CD, Gause KC, Dey M, Wisehart-Johnson AE, Spivey EC and Meier KE (1994) Activation of MAP kinases and PLD in A7r5 vascular smooth muscle cells. J Biol Chem 269:23790-23799.
18. 2+ rather than PKC is the major factor to activate PLD in FMLP-stimulated rabbit peritoneal neutrophils. Possible involvement of calmodulin/myosin L chain kinase pathway. J Immunol 149:622-628.
19. Kelloff GJ, Lubet RA, Fay JR, Steele VE, Boone CW, Crowell JA and Sigmann CC (1997) Farnesyl protein transferase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomarkers Prev 6:267-282.
20. Kiss Z (1996) Regulation of PLD by PKC. Chem Phys Lipids 80:81-102.
21. 2+ ions in VSMC. Am J Physiol 270:H1031-H1037.
22. Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A and Davis RJ (1993) cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278.
23. 1Adrenergic receptor-mediated activation of PLD in rat cerebral cortex. J Biol Chem 267:3679-3685.
24. Malcolm KC, Ross AH, Qiu RG, Symons M and Exton JH (1994) Activation of rat liver PLD by the small GTP-binding protein RhoA. J Biol Chem 269:25951-25954.
25. Manne V, Ricca CS, Brown JG, Tuomari AV, Van N, Patel D, Schmidt R, Lynch MJ, Ciosek CP Jr, Carboni JM, Robinson S, Gordon EM, Barbacid M, Seizinger BR and Biller SA (1995) Ras farnesylation as a target for novel antitumor agents: Potent and selective farnesyl diphosphate analog inhibitors of farnesyltransferase. Drug Dev Res 34:121-137.
26. 1 can be tyrosine-phosphorylated. J Biol Chem 272:20660-20664.
27. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR and Malik KU (1998) 20-Hydroxyeicosatetraenoic acid mediates CaM kinase II-induced MAP kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 95: 12701-12706.
28. 2 in norepinephrine-induced arachidonic acid release in rabbit aortic smooth muscle cells. J Biol Chem 271:30149-30157.
29. Natarajan V, Scribner WM, Hart CM and Parthasarathy S (1995) Oxidized low density lipoprotein-mediated activation of PLD in smooth muscle cells: A possible role in cell proliferation and atherogenesis. J Lipid Res 80:103-116.
30. 1 can be tyrosine-phosphorylated. Chem Phys Lipids 80:103-116.
31. 1A adrenergic receptors in cultured smooth muscle cells of rabbit aorta. J Pharmacol Exp Ther 260:849-858.
32. Pettitt TR, Martin A, Horton T, Liossis C, Lord JM and Wakelam MJO (1997) Diacylglycerol and phosphatidate generated by phospholipases C and D, respectively, have distinct fatty acid compositions and functions. PLD-derived diacylglycerol does not activate PKC in porcine aortic endothelial cells. J Biol Chem 272:17354-17359.
33. Resh MD (1996) Regulation of cellular signalling by fatty acid acylation and prenylation of signal transduction proteins. Cell Signal 8:403-412.
34. Rizzo MA, Shome K, Vasudevan C, Stolz DB, Sung TC, Frohman MA, Watkins SC and Romero G (1999) Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway. J Biol Chem 274:1131-1139.
35. 1A Adrenergic receptor stimulation with phenylephrine promotes arachidonic acid release by activation of PLD in rat-1 fibroblasts: Inhibition by protein kinase A. J Pharmacol Exp Ther 284:576-585.
36. 2 in Swiss 3T3 fibroblasts. J Biol Chem 273:29986-29994.
37. Sik Min D, Park S and Exton JH (1998a) Characterization of a rat brain PLD isozyme. J Biol Chem 273:7044-7051.
38. 2 complexes with the EGF receptor and undergoes tyrosine phosphorylation at a single site upon agonist stimulation. J Biol Chem 273:33722-33727.
39. Song J, Pfeffer LM and Foster DA (1991) v-Src-increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine. Mol Cell Biol 11:4903-4908.
40. 2+ influx. Atherosclerosis 12:119-127.
41. 2+ into adrenal glomerulosa cells. Endocr J 1:279-284.
42. Wilkie N, Morton C, Ng L and Boarder MH (1996) Stimulated MAP kinase is necessary but not sufficient for the mitogenic response to angiotensin II. A role for PLD. J Biol Chem 271:32447-32453.
43. Yasuda I, Kishimoto A, Tanaka S, Tominaga M, Sakurali A and Nishizuka Y (1990) A synthetic peptide substrate for selective assay of PKC. Biochem Biophys Res Commun 166:1220-1227.
44. Ye H, Wolf RA, Kurz T and Corr BP (1994) Phosphatidic acid increases in response to noradrenaline and endothelin-1 in adult rabbit ventricular myocytes. Cardiavase Res 28:1828-1834.
45. Zhang XF, Settleman J, Kyriakis JM, Takeuchi-Suzuki E, Elledge SJ, Marshall MS, Bruder JT, Rapp UR and Avruch J (1993) Normal and oncogenic p21 Ras protein bind to the amino terminal regulatory domain of c-Raf-1. Nature (Lond) 364:308-313.